Reuters logo
BRIEF-Xbrane Biopharma Q4 loss before interest and tax widens to SEK 10.2 million
February 27, 2017 / 7:21 AM / 9 months ago

BRIEF-Xbrane Biopharma Q4 loss before interest and tax widens to SEK 10.2 million

Feb 27 (Reuters) - Xbrane Biopharma AB:

* Q4 net sales 532,503 Swedish crowns ($58,997) versus 83,736 crowns year ago

* Q4 loss before interest and tax 10.2 million crowns versus loss 5.0 million crowns year ago Source text for Eikon: Further company coverage: ($1 = 9.0260 Swedish crowns) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below